These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8096664)

  • 1. [Salazopyrine desensitization].
    Schydlowsky P
    Ugeskr Laeger; 1993 Feb; 155(7):476-8. PubMed ID: 8096664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Salazopyrine desensitization].
    Rasmussen E; Lykkegaard JJ
    Ugeskr Laeger; 1993 May; 155(18):1398. PubMed ID: 8098882
    [No Abstract]   [Full Text] [Related]  

  • 3. Clopidogrel desensitization: case report and review of published protocols.
    Owen P; Garner J; Hergott L; Page RL
    Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE; Amos RS
    Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphasalazine desensitisation in patients with arthritis.
    McCarthy C; Coughlan R
    Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization for sulfasalazine-induced skin rash in a patient with ulcerative colitis.
    Akahoshi K; Chijiiwa Y; Kabemura T; Okabe H; Akamine Y; Nawata H
    J Gastroenterol; 1994 Dec; 29(6):772-5. PubMed ID: 7874275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of desensitization to allopurinol following cutaneous reactions.
    Fam AG; Dunne SM; Iazzetta J; Paton TW
    Arthritis Rheum; 2001 Jan; 44(1):231-8. PubMed ID: 11212165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Desensitization to salazopyrine in rheumatoid polyarthritis].
    Lioté F; Kuntz D
    Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):139. PubMed ID: 1675020
    [No Abstract]   [Full Text] [Related]  

  • 9. Desensitization to sulphasalazine in patients with arthritis.
    Koski JM
    Clin Exp Rheumatol; 1993; 11(2):169-70. PubMed ID: 8099541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of sulfasalazine: the gastroenterologists' experience.
    Sachar DB
    J Rheumatol Suppl; 1988 Sep; 16():14-6. PubMed ID: 2903923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine desensitisation.
    Holdsworth CD
    Br Med J (Clin Res Ed); 1981 Jan; 282(6258):110. PubMed ID: 6109553
    [No Abstract]   [Full Text] [Related]  

  • 12. [Perinatal consequences of maternal connective tissue diseases: a prospective study of 73 cases].
    Renaud C; de Montgolfier I; Vautier-Brouzes D; Costedoat-Chalumeau N; Lapillonne A; Gold F
    Arch Pediatr; 2006 Nov; 13(11):1386-90. PubMed ID: 17011758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel (Plavix) desensitization: a case series.
    Camara MG; Almeda FQ
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):525-7. PubMed ID: 15973671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat.
    Shenton JM; Teranishi M; Abu-Asab MS; Yager JA; Uetrecht JP
    Chem Res Toxicol; 2003 Sep; 16(9):1078-89. PubMed ID: 12971795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfasalazine: II. Some notes on the discovery and development of salazopyrin.
    Svartz N
    Am J Gastroenterol; 1988 May; 83(5):497-503. PubMed ID: 2896459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful clopidogrel desensitization after drug-eluting stent implantation.
    Kammer RT
    J Invasive Cardiol; 2009 Mar; 21(3):134-5. PubMed ID: 19258645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
    Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.
    Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Chantratita W; Nakamura Y
    Pharmacogenet Genomics; 2009 Feb; 19(2):139-46. PubMed ID: 19104471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory severe connective tissue disease thrombocytopenia: is rituximab treatment effective and safe?
    Zheng WJ; Zhang X; Wang Q; Xu D; Zeng XF; Zhang FC
    Ann Rheum Dis; 2009 Jun; 68(6):1077-8. PubMed ID: 19435726
    [No Abstract]   [Full Text] [Related]  

  • 20. Salazopyrin EN-tabs: an enteric-coated case that is hard to take.
    Drug Ther Bull; 1987 Jul; 25(14):53-5. PubMed ID: 2886326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.